173 related articles for article (PubMed ID: 15583749)
1. Platelet deposition on stainless steel, spiral, and braided polylactide stents. A comparative study.
Hietala EM; Maasilta P; Juuti H; Nuutinen JP; Harjula AL; Salminen US; Lassila R
Thromb Haemost; 2004 Dec; 92(6):1394-401. PubMed ID: 15583749
[TBL] [Abstract][Full Text] [Related]
2. Platelet responses and coagulation activation on polylactide and heparin-polycaprolactone-L-lactide-coated polylactide stent struts.
Hietala EM; Maasilta P; Välimaa T; Harjula AL; Törmälä P; Salminen US; Lassila R
J Biomed Mater Res A; 2003 Dec; 67(3):785-91. PubMed ID: 14613226
[TBL] [Abstract][Full Text] [Related]
3. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.
Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818
[TBL] [Abstract][Full Text] [Related]
4. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
[TBL] [Abstract][Full Text] [Related]
5. Antithrombogenic coating of stents using a biodegradable drug delivery technology.
Herrmann R; Schmidmaier G; Märkl B; Resch A; Hähnel I; Stemberger A; Alt E
Thromb Haemost; 1999 Jul; 82(1):51-7. PubMed ID: 10456454
[TBL] [Abstract][Full Text] [Related]
6. Reduced platelet adhesion and improved corrosion resistance of superhydrophobic TiO₂-nanotube-coated 316L stainless steel.
Huang Q; Yang Y; Hu R; Lin C; Sun L; Vogler EA
Colloids Surf B Biointerfaces; 2015 Jan; 125():134-41. PubMed ID: 25481855
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA
J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989
[TBL] [Abstract][Full Text] [Related]
8. Coating of poly(p-xylylene) by PLA-PEO-PLA triblock copolymers with excellent polymer-polymer adhesion for stent applications.
Hanefeld P; Westedt U; Wombacher R; Kissel T; Schaper A; Wendorff JH; Greiner A
Biomacromolecules; 2006 Jul; 7(7):2086-90. PubMed ID: 16827574
[TBL] [Abstract][Full Text] [Related]
9. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility.
Yang Z; Wang J; Luo R; Maitz MF; Jing F; Sun H; Huang N
Biomaterials; 2010 Mar; 31(8):2072-83. PubMed ID: 20022107
[TBL] [Abstract][Full Text] [Related]
10. Reduced thrombus formation by hyaluronic acid coating of endovascular devices.
Verheye S; Markou CP; Salame MY; Wan B; King SB; Robinson KA; Chronos NA; Hanson SR
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1168-72. PubMed ID: 10764689
[TBL] [Abstract][Full Text] [Related]
11. Surface fluorination of polylactide as a path to improve platelet associated hemocompatibility.
Khalifehzadeh R; Ciridon W; Ratner BD
Acta Biomater; 2018 Sep; 78():23-35. PubMed ID: 30036719
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance evaluation of luminal patency after polylactide stent implantation: an experimental study in a rabbit aorta model.
Hietala EM; Maasilta P; Ståhls A; Salminen US; Harjula AL; Välimaa T; Kivisaari L
Eur Radiol; 2003 May; 13(5):1025-32. PubMed ID: 12695824
[TBL] [Abstract][Full Text] [Related]
14. Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery.
Huang LY; Yang MC
J Nanosci Nanotechnol; 2006; 6(9-10):3163-70. PubMed ID: 17048532
[TBL] [Abstract][Full Text] [Related]
15. Heparin conjugated polylactide as a blood compatible material.
Jee KS; Park HD; Park KD; Kim YH; Shin JW
Biomacromolecules; 2004; 5(5):1877-81. PubMed ID: 15360301
[TBL] [Abstract][Full Text] [Related]
16. Substantial reduction of platelet adhesion by heparin-coated stents.
Bickel C; Rupprecht HJ; Darius H; Binz C; Hauröder B; Krummenauer F; Meyer J
J Interv Cardiol; 2001 Aug; 14(4):407-13. PubMed ID: 12053494
[TBL] [Abstract][Full Text] [Related]
17. Platelet compatibility of an artificial surface modified with functionally active heparin.
Mollnes TE; Videm V; Christiansen D; Bergseth G; Riesenfeld J; Hovig T
Thromb Haemost; 1999 Sep; 82(3):1132-6. PubMed ID: 10494777
[TBL] [Abstract][Full Text] [Related]
18. Hemocompatibility and anti-fouling behavior of multilayer biopolymers immobilized on gold-thiolized drug-eluting cardiovascular stents.
Huang LY; Yang MC; Tsou HM; Liu TY
Colloids Surf B Biointerfaces; 2019 Jan; 173():470-477. PubMed ID: 30326363
[TBL] [Abstract][Full Text] [Related]
19. Innovative coating based on graphene and their decorated nanoparticles for medical stent applications.
ElSawy AM; Attia NF; Mohamed HI; Mohsen M; Talaat MH
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():708-715. PubMed ID: 30606584
[TBL] [Abstract][Full Text] [Related]
20. Surface modification of metallic cardiovascular stents by strongly adhering aliphatic polyester coatings.
Jérôme C; Aqil A; Voccia S; Labaye DE; Maquet V; Gautier S; Bertrand OF; Jérôme R
J Biomed Mater Res A; 2006 Mar; 76(3):521-9. PubMed ID: 16317721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
